BeStock  
Markets › Compare › GMAB vs INSM

GMAB vs INSM

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
GMAB · Genmab$50.60 ▼ 1.46%
INSM · Insmed$141.33 ▼ 2.17%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

3676115155194Nov 24, '25May 26, '26Nov 20, '26
  • GMAB +64.2%
  • INSM -31.7%

Head to head

MetricGMABINSM
Price$50.60$141.33
Change today▼ 1.46%▼ 2.17%
Market cap$31.20B$31.01B
Return, 3 months+53.2%+14.0%
Return, year to date+64.3%-18.8%
Return, 1 year+66.2%-28.9%
P/E (TTM)43.2–
P/B4.942.7
P/E percentile vs own 5y81st0th
Dividend yield––
Revenue growth (YoY, latest qtr)+16.1%+268.4%
Net profit growth (YoY)-14.7%+72.9%
Gross margin92.7%84.4%
Operating margin30.6%-41.7%
Net margin17.0%-39.9%
Return on equity12.1%-72.5%
Analyst target vs. price+27.6%+35.2%
Analyst buy share89%94%
RSI (14)5573
30-day volatility83.5%75.8%
Max drawdown, 1 year-32.5%-56.5%
Trend readLeaning bullishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • GMAB is the largest of the group by market value.
  • GMAB has returned the most over the past year.
  • INSM is growing revenue fastest.
  • GMAB keeps the most profit per dollar of sales.
  • INSM has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top